A citation-based method for searching scientific literature

Naveena Singh, Anna M Piskorz, Tjalling Bosse, Mercedes Jimenez-Linan, Brian Rous, James D Brenton, C Blake Gilks, Martin Köbel. J Pathol 2020
Times Cited: 63







List of co-cited articles
341 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Integrated genomic characterization of endometrial carcinoma.
Cyriac Kandoth, Nikolaus Schultz, Andrew D Cherniack, Rehan Akbani, Yuexin Liu, Hui Shen, A Gordon Robertson, Itai Pashtan, Ronglai Shen, Christopher C Benz,[...]. Nature 2013
61

Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts.
Ellen Stelloo, Remi A Nout, Elisabeth M Osse, Ina J Jürgenliemk-Schulz, Jan J Jobsen, Ludy C Lutgens, Elzbieta M van der Steen-Banasik, Hans W Nijman, Hein Putter, Tjalling Bosse,[...]. Clin Cancer Res 2016
304
44

Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series.
S Kommoss, M K McConechy, F Kommoss, S Leung, A Bunz, J Magrill, H Britton, F Kommoss, F Grevenkamp, A Karnezis,[...]. Ann Oncol 2018
201
42

Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
Aline Talhouk, Melissa K McConechy, Samuel Leung, Winnie Yang, Amy Lum, Janine Senz, Niki Boyd, Judith Pike, Michael Anglesio, Janice S Kwon,[...]. Cancer 2017
291
41

A clinically applicable molecular-based classification for endometrial cancers.
A Talhouk, M K McConechy, S Leung, H H Li-Chang, J S Kwon, N Melnyk, W Yang, J Senz, N Boyd, A N Karnezis,[...]. Br J Cancer 2015
336
39

Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas.
Alicia León-Castillo, Ester Gilvazquez, Remi Nout, Vincent Thbm Smit, Jessica N McAlpine, Melissa McConechy, Stefan Kommoss, Sara Y Brucker, Joseph W Carlson, Elisabeth Epstein,[...]. J Pathol 2020
87
38

Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma.
Martin Köbel, Anna M Piskorz, Sandra Lee, Shuhong Lui, Cecile LePage, Francesco Marass, Nitzan Rosenfeld, Anne-Marie Mes Masson, James D Brenton. J Pathol Clin Res 2016
184
38

Interpretation of somatic POLE mutations in endometrial carcinoma.
Alicia León-Castillo, Heidi Britton, Melissa K McConechy, Jessica N McAlpine, Remi Nout, Stefan Kommoss, Sara Y Brucker, Joseph W Carlson, Elisabeth Epstein, Tilman T Rau,[...]. J Pathol 2020
81
30

Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma.
C Blake Gilks, Esther Oliva, Robert A Soslow. Am J Surg Pathol 2013
199
30

Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas: Toward Increased Reproducibility.
Martin Köbel, Brigitte M Ronnett, Naveena Singh, Robert A Soslow, C Blake Gilks, W Glenn McCluggage. Int J Gynecol Pathol 2019
123
30

Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative.
Ellen Stelloo, Tjalling Bosse, Remi A Nout, Helen J MacKay, David N Church, Hans W Nijman, Alexandra Leary, Richard J Edmondson, Melanie E Powell, Emma J Crosbie,[...]. Mod Pathol 2015
229
26

Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment.
Aline Talhouk, Lien N Hoang, Melissa K McConechy, Quentin Nakonechny, Joyce Leo, Angela Cheng, Samuel Leung, Winnie Yang, Amy Lum, Martin Köbel,[...]. Gynecol Oncol 2016
97
26

Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy.
Alicia León-Castillo, Stephanie M de Boer, Melanie E Powell, Linda R Mileshkin, Helen J Mackay, Alexandra Leary, Hans W Nijman, Naveena Singh, Pamela M Pollock, Paul Bessette,[...]. J Clin Oncol 2020
126
23

Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups.
Tjalling Bosse, Remi A Nout, Jessica N McAlpine, Melissa K McConechy, Heidi Britton, Yaser R Hussein, Carlene Gonzalez, Raji Ganesan, Jane C Steele, Beth T Harrison,[...]. Am J Surg Pathol 2018
112
22

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up.
N Colombo, C Creutzberg, F Amant, T Bosse, A González-Martín, J Ledermann, C Marth, R Nout, D Querleu, M R Mirza,[...]. Ann Oncol 2016
503
20

Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu.
Amanda N Fader, Dana M Roque, Eric Siegel, Natalia Buza, Pei Hui, Osama Abdelghany, Setsuko K Chambers, Angeles Alvarez Secord, Laura Havrilesky, David M O'Malley,[...]. J Clin Oncol 2018
171
17

The genetic landscape of endometrial clear cell carcinomas.
Deborah F DeLair, Kathleen A Burke, Pier Selenica, Raymond S Lim, Sasinya N Scott, Sumit Middha, Abhinita S Mohanty, Donavan T Cheng, Michael F Berger, Robert A Soslow,[...]. J Pathol 2017
104
17

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.
Nicole Concin, Xavier Matias-Guiu, Ignace Vergote, David Cibula, Mansoor Raza Mirza, Simone Marnitz, Jonathan Ledermann, Tjalling Bosse, Cyrus Chargari, Anna Fagotti,[...]. Int J Gynecol Cancer 2021
223
17

Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis.
Melissa K McConechy, Aline Talhouk, Samuel Leung, Derek Chiu, Winnie Yang, Janine Senz, Linda J Reha-Krantz, Cheng-Han Lee, David G Huntsman, C Blake Gilks,[...]. Clin Cancer Res 2016
97
15

Incorporation of molecular characteristics into endometrial cancer management.
Lisa Vermij, Vincent Smit, Remi Nout, Tjalling Bosse. Histopathology 2020
66
15

Reproducibility of histological cell type in high-grade endometrial carcinoma.
Guangming Han, Davinder Sidhu, Máire A Duggan, Jocelyne Arseneau, Matthew Cesari, Philip B Clement, Carol A Ewanowich, Steve E Kalloger, Martin Köbel. Mod Pathol 2013
122
15

Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status.
Basile Tessier-Cloutier, Kim E Kortekaas, Emily Thompson, Jennifer Pors, Julia Chen, Julie Ho, Leah M Prentice, Melissa K McConechy, Christine Chow, Lily Proctor,[...]. Mod Pathol 2020
39
25

Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations.
Yaser R Hussein, Britta Weigelt, Douglas A Levine, J Kenneth Schoolmeester, Linda N Dao, Bonnie L Balzer, Georgia Liles, Beth Karlan, Martin Köbel, Cheng-Han Lee,[...]. Mod Pathol 2015
118
14


CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence.
Katherine C Kurnit, Grace N Kim, Bryan M Fellman, Diana L Urbauer, Gordon B Mills, Wei Zhang, Russell R Broaddus. Mod Pathol 2017
123
14


High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.
Rajmohan Murali, Ben Davidson, Oluwole Fadare, Joseph A Carlson, Christopher P Crum, C Blake Gilks, Julie A Irving, Anais Malpica, Xavier Matias-Guiu, W Glenn McCluggage,[...]. Int J Gynecol Pathol 2019
87
14


Prognostic significance of POLE proofreading mutations in endometrial cancer.
David N Church, Ellen Stelloo, Remi A Nout, Nadejda Valtcheva, Jeroen Depreeuw, Natalja ter Haar, Aurelia Noske, Frederic Amant, Ian P M Tomlinson, Peter J Wild,[...]. J Natl Cancer Inst 2014
176
12

Adjuvant Treatment for POLE Proofreading Domain-Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues.
Inge C Van Gool, Emily Rayner, Elisabeth M Osse, Remi A Nout, Carien L Creutzberg, Ian P M Tomlinson, David N Church, Vincent T H B M Smit, Niels de Wind, Tjalling Bosse,[...]. Clin Cancer Res 2018
33
24

An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer.
Casey M Cosgrove, David L Tritchler, David E Cohn, David G Mutch, Craig M Rush, Heather A Lankes, William T Creasman, David S Miller, Nilsa C Ramirez, Melissa A Geller,[...]. Gynecol Oncol 2018
56
14

Integrated Molecular Characterization of Uterine Carcinosarcoma.
Andrew D Cherniack, Hui Shen, Vonn Walter, Chip Stewart, Bradley A Murray, Reanne Bowlby, Xin Hu, Shiyun Ling, Robert A Soslow, Russell R Broaddus,[...]. Cancer Cell 2017
197
12

Practical guidance for mismatch repair-deficiency testing in endometrial cancer.
E Stelloo, A M L Jansen, E M Osse, R A Nout, C L Creutzberg, D Ruano, D N Church, H Morreau, V T H B M Smit, T van Wezel,[...]. Ann Oncol 2017
101
11

Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas.
Marthe M de Jonge, Aurélie Auguste, Lise M van Wijk, Philip C Schouten, Matty Meijers, Natalja T Ter Haar, Vincent T H B M Smit, Remi A Nout, Mark A Glaire, David N Church,[...]. Clin Cancer Res 2019
65
11

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study.
Henry M Keys, James A Roberts, Virginia L Brunetto, Richard J Zaino, Nick M Spirtos, Jeffrey D Bloss, Andrew Pearlman, Mitchell A Maiman, Jeffrey G Bell. Gynecol Oncol 2004
11

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.
C L Creutzberg, W L van Putten, P C Koper, M L Lybeert, J J Jobsen, C C Wárlám-Rodenhuis, K A De Winter, L C Lutgens, A C van den Bergh, E van de Steen-Banasik,[...]. Lancet 2000
11

Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis.
Anna Yemelyanova, Russell Vang, Malti Kshirsagar, Dan Lu, Morgan A Marks, Ie Ming Shih, Robert J Kurman. Mod Pathol 2011
303
11

Histotype-genotype correlation in 36 high-grade endometrial carcinomas.
Lien N Hoang, Melissa K McConechy, Martin Köbel, Guangming Han, Marjan Rouzbahman, Ben Davidson, Julie Irving, Rola H Ali, Sam Leung, Jessica N McAlpine,[...]. Am J Surg Pathol 2013
82
11

Interobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular Subgroup.
Lien N Hoang, Mary A Kinloch, Joyce M Leo, Katherine Grondin, Cheng-Han Lee, Carol Ewanowich, Martin Köbel, Angela Cheng, Aline Talhouk, Melissa McConechy,[...]. Am J Surg Pathol 2017
51
13

Molecular subtypes of clear cell carcinoma of the endometrium: Opportunities for prognostic and predictive stratification.
Soyoun Rachel Kim, Basile Tessier Cloutier, Samuel Leung, Dawn Cochrane, Heidi Britton, Annick Pina, Claudine Storness-Bliss, David Farnell, Leo Huang, Kathryn Shum,[...]. Gynecol Oncol 2020
31
22

POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium.
Bo Meng, Lien N Hoang, John B McIntyre, Máire A Duggan, Gregg S Nelson, Cheng-Han Lee, Martin Köbel. Gynecol Oncol 2014
120
9

A panoply of errors: polymerase proofreading domain mutations in cancer.
Emily Rayner, Inge C van Gool, Claire Palles, Stephen E Kearsey, Tjalling Bosse, Ian Tomlinson, David N Church. Nat Rev Cancer 2016
198
9

Mismatch repair deficiency as a predictive marker for response to adjuvant radiotherapy in endometrial cancer.
Casper Reijnen, Heidi V N Küsters-Vandevelde, Clemens F Prinsen, Leon F A G Massuger, Marc P M L Snijders, Stefan Kommoss, Sara Y Brucker, Janice S Kwon, Jessica N McAlpine, Johanna M A Pijnenborg. Gynecol Oncol 2019
41
14

Impact of TP53 immunohistochemistry on the histological grading system for endometrial endometrioid carcinoma.
Mitsutake Yano, Kozue Ito, Akira Yabuno, Naoki Ogane, Tomomi Katoh, Mariko Miyazawa, Masaki Miyazawa, Kosei Hasegawa, Hisashi Narahara, Masanori Yasuda. Mod Pathol 2019
16
37

Regression of Chemotherapy-Resistant Polymerase ε (POLE) Ultra-Mutated and MSH6 Hyper-Mutated Endometrial Tumors with Nivolumab.
Alessandro D Santin, Stefania Bellone, Natalia Buza, Jungmin Choi, Peter E Schwartz, Joseph Schlessinger, Richard P Lifton. Clin Cancer Res 2016
102
9


PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
Dung T Le, Jennifer N Uram, Hao Wang, Bjarne R Bartlett, Holly Kemberling, Aleksandra D Eyring, Andrew D Skora, Brandon S Luber, Nilofer S Azad, Dan Laheru,[...]. N Engl J Med 2015
9

Histopathological features of endometrial carcinomas associated with POLE mutations: implications for decisions about adjuvant therapy.
Salwa Bakhsh, Mary Kinloch, Lien N Hoang, Robert A Soslow, Martin Köbel, Cheng-Han Lee, Jessica N McAlpine, Melissa K McConechy, C Blake Gilks. Histopathology 2016
42
14

Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.
Robert A Soslow, Carmen Tornos, Kay J Park, Anais Malpica, Xavier Matias-Guiu, Esther Oliva, Vinita Parkash, Joseph Carlson, W Glenn McCluggage, C Blake Gilks. Int J Gynecol Pathol 2019
95
9

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.
Aurelien Marabelle, Dung T Le, Paolo A Ascierto, Anna Maria Di Giacomo, Ana De Jesus-Acosta, Jean-Pierre Delord, Ravit Geva, Maya Gottfried, Nicolas Penel, Aaron R Hansen,[...]. J Clin Oncol 2020
711
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.